Wang Tao, Yang Yang, Feng Huayi, Cui Bo, Lv Zheng, Zhao Wenlei, Zhang Xiangyi, Ma Xin
Department of Urology, The Third Medical Centre, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
Front Oncol. 2022 May 19;12:877470. doi: 10.3389/fonc.2022.877470. eCollection 2022.
Birt-Hogg-Dube syndrome is an autosomal dominant condition that arises from germline folliculin (FLCN) mutations. It is characterized by skin fibrofolliculomas, lung cysts, pneumothorax, and renal cancer. Here, we present the case of a 36-year-old woman with asymptomatic, multiple renal tumors and a history of spontaneous pneumothorax. Genetic analysis revealed a hotspot FLCN germline mutation, c.1285dupC (p.H429fs), and a novel somatic mutation, c.470delT (p.F157fs). This information and the results of immunohistochemical analysis of the renal tumors indicated features compatible with a tumor suppressor role of FLCN. Two transcription factors, oncogenic TFEB and TFE3, were shown to be regulated by FLCN inactivation, which results in their nuclear localization. We showed that a deficiency in the tumor suppressor FLCN leads to deregulation of the mammalian target of rapamycin signaling (mTOR) pathway. A potential link between FLCN mutation and ciliary length was also examined. Thus, the mutation identified in our patient provides novel insights into the relationship among FLCN mutations, TFEB/TFE3, mTOR, and cilia. However, an in-depth understanding of the role of folliculin in the molecular pathogenesis of renal cancer requires further study.
Birt-Hogg-Dube综合征是一种常染色体显性遗传病,由种系卵泡抑素(FLCN)突变引起。其特征为皮肤纤维毛囊瘤、肺囊肿、气胸和肾癌。在此,我们报告一例36岁女性病例,该患者有无症状多发性肾肿瘤且有自发性气胸病史。基因分析显示一个热点FLCN种系突变,即c.1285dupC(p.H429fs),以及一个新的体细胞突变,即c.470delT(p.F157fs)。这些信息以及肾肿瘤的免疫组化分析结果表明,其特征与FLCN的肿瘤抑制作用相符。研究显示,两种转录因子,即致癌性转录因子EB(TFEB)和转录因子E3(TFE3)受FLCN失活调控,这导致它们定位于细胞核。我们发现肿瘤抑制因子FLCN的缺陷会导致雷帕霉素信号通路的哺乳动物靶点(mTOR)失调。我们还研究了FLCN突变与纤毛长度之间的潜在联系。因此,我们在患者中鉴定出的突变,为深入了解FLCN突变、TFEB/TFE3、mTOR与纤毛之间的关系提供了新线索。然而,要深入了解卵泡抑素在肾癌分子发病机制中的作用,还需要进一步研究。